Complementary & Alternative Medicine Market Poised to Expand at a Robust Pace Over 2028

 

Complementary And Alternative Medicine Market Growth & Trends

The global complementary and alternative medicine market size is expected to reach USD 404.66 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.03% from 2021 to 2028. The market has witnessed a significant expansion in its consumer base in recent years owing to the benefits and philosophies that have the potential to attract customers.

The core philosophies of alternative medicine practices and complementary therapies include high preference to natural products as compared to synthetic ones, avoiding implementation of quick-fix type therapies, ensuring sufficient duration is given for healing, the onset of any illness is attributed to body-imbalance, the body has the ability to heal itself, the whole patient has to be treated and not just a specific diseased body part, and gentle therapies have to be administered before the harsh ones.

The most commonly administered and popular complementary therapies include Alexander technique, acupuncture, herbal medicine, homeopathy, aromatherapy, reiki, naturopathy, and yoga. Profitable business expansion strategies are being adopted by not only market participants but also by medical settings to ensure effective marketing and promotion of alternative medicine therapies.

Yoga, mind, and body-oriented traditional medicines are expected to gain significant traction in the coming years. Expanding applications of yoga and mind healing across chronic ailments, such as cancer, diabetes, COVID-19, and cardiovascular diseases, are set to contribute to the growth of the mind healing intervention segment.

More than half of physicians based in office set-ups in the U.S. have recommended at least one complementary health intervention to their patients, as reported by a survey published in January 2020. Additionally, a large number of female physicians integrate alternative medicine approaches, whereas male physicians most commonly recommend osteopathic manipulation and chiropractic treatment interventions. An increase in the number of such surveys is expected to enable physicians, consumers, and medical schools to gain a better understanding of the potential differences in complementary and alternative medicine use.

Companies are initiating strategic product developments to sustain the market competition. For instance, in July 2019, Colombia Nutritional launched a new process solution having a multi-phase onboarding feature designed for the efficient online launch of the latest products. The key objective of this strategic product development was to maintain minimum order quantity (MOQ) that would further improve the quality of service provided.

Request a free sample copy or view report summary: Complementary And Alternative Medicine Market Report

Complementary And Alternative Medicine Market Report Highlights

• By intervention, traditional alternative medicine or botanicals dominated the market with a share of 38.48% in 2020. Botanicals are among the prominent forms of alternative treatment practices, inclusive of natural and herbal treatment supplements, coupled with therapeutic interventions, incorporating herbs, oils, and other curative supplements
• In the body healing intervention segment, yoga held the largest share of 36.27% in 2020. In the mind healing segment, hypnotherapy is expected to exhibit the fastest CAGR of 22.44% from 2021 to 2028
• Europe held the largest share of 33.35% in 2020 owing to the extended research efforts targeted toward bringing CAM practices to the mainstream medicine
• The Middle East and Africa is expected to expand at the fastest CAGR of 24.78% from 2021 to 2028
• Based on distribution method, distance correspondence and e-sales are expected to witness significant lucrative opportunities in the near future, particularly attributed to the lockdown and social distancing implications associated with the recent pandemic outbreak of COVID-19 across the globe

Complementary And Alternative Medicine Market Segmentation

Grand View Research has segmented the global complementary and alternative medicine market on the basis of intervention, distribution method, and region:

Complementary And Alternative Medicine Intervention Outlook (Revenue, USD Billion, 2017 – 2028)

• Traditional Alternative Medicine/Botanicals
  • Ayurveda
  • Apitherapy
  • Bach Flower Therapy
  • Naturopathic Medicine
  • Traditional Chinese Medicine
  • Traditional Korean Medicine
  • Traditional Japanese Medicine
  • Traditional Mongolian Medicine
  • Traditional Tibetan Medicine
  • Zang Fu Theory
• Mind Healing
  • Autosuggestion
  • Hypnotherapy
  • Neuro-linguistic Programming
  • Self-hypnosis
  • Spiritual Mind Treatment
  • Transcendental Meditation
• Body Healing
  • Acupressure
  • Acupuncture
  • Alexander Technique
  • Auriculotherapy
  • Autogenic Training
  • Chiropractic
  • Cupping Therapy
  • Kinesiology
  • Osteomyology
  • Osteopathy
  • Pilates
  • Qigong
  • Reflexology
  • Yoga
• External Energy
  • Magnetic Therapy
    • Bio-magnetic Therapy
    • Magnetic Resonance Therapy
  • Radionics
  • Reiki
  • Therapeutic Touch
  • Chakra Healing
• Sensory Healing
  • Aromatherapy
  • Music therapy
  • Sonopuncture
  • Sound Therapy

Complementary And Alternative Medicine Distribution Method Outlook (Revenue, USD Billion, 2017 – 2028)

• Direct Sales
• E-sales
• Distance Correspondence

Complementary And Alternative Medicine Regional Outlook (Revenue, USD Billion, 2017 – 2028)

• North America
  • US.
  • Canada
• Europe
  • France
  • Germany
  • Switzerland
  • Austria
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Belgium
  • Netherlands
  • UK.
  • Ireland
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Hong Kong
  • Singapore
  • New Zealand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Israel
  • UAE
  • South Africa

List of Key Players of Complementary And Alternative Medicine Market

• Columbia Nutritional
• Herb Pharm
• Herbal Hills
• Ramamani Iyengar Memorial Yoga Institute
• John Schumacher Unity Woods Yoga Centre
• Yoga Tree Studios, Inc.
• Helio USA Inc.
• NatureKue
• Nordic Nutraceuticals
• Pure encapsulations, LLC.
• The Healing Company Ltd.
• Quantum-Touch
• BIOTAILOR
• Bikram Yoga
• True Yoga
• Amrita Ayurveda & Yoga
• AYUSH Ayurvedic Pte Ltd.
• Sheng Chang Pharmaceutical Company
• LKK Health Products Group Limited
• Body & Soul Yoga Club
• Namat Fitness Management (Shanghai) Co., Ltd. (Y+)
• ALCES LLP

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Next-Generation Sequencing Data Analysis Market is Estimated To Attain USD 1.72 Billion by 2028

 Next-Generation Sequencing Data Analysis Market Growth & Trends

The global next-generation sequencing data analysis market size is expected to reach USD 1.72 billion by 2028 registering a CAGR of 15.02%, according to a new report by Grand View Research, Inc. Key drivers contributing to market expansion include the growing adoption of sequencing platforms for clinical diagnosis because of a significant reduction in the cost of installation. The easy availability of genomic and proteomic data is also expected to create lucrative growth opportunities in this market during the forecast period.

In addition, a decrease in the cost of sequencing is expected to increase the adoption of next-generation sequencing (NGS), which, in turn, is likely to boost the market growth. Availability of tools, such as Agilent’s HaloPlex capture system and Targeted Methyl-Seq platform from EpiGentek Group Inc., has helped in the determination of DNA methylation profiles in individual genomes. An increase in the adoption of bisulfite-methylation for targeted sequencing and targeted methylation NGS data analysis methods is anticipated to propel market growth.

EpigenDx, CD Genomics, Novogene Co., Ltd., and Epigentek Group, Inc. are the key players that offer methylation sequencing and targeted bisulfite sequencing data analysis services. The launch of new products will further boost revenue generation in the market. Major market participants have undertaken various strategic initiatives to strengthen their position in the market. For instance, in January 2021, Transnetyx, Inc. collaborated with One Codex to provide end-to-end analysis and microbiome sequencing services. This is expected to offer affordable sequencing analysis services to researchers.

Request a free sample copy or view report summary: Next-Generation Sequencing Data Analysis Market Report

Next-Generation Sequencing Data Analysis Market Report Highlights

• Services dominated the products segment in 2020 and will retain the leading position growing at the fastest CAGR during the forecast period
• Although NGS is advantageous in terms of affordability and speed, many research entities are unable to adopt it owing to a lack of sufficient computational infrastructure and skilled professionals to analyze the generated information
• Therefore, institutions that lack provision for data interpretation, analysis, and management adopt platforms & services offered by other companies in the market
• Tertiary analysis occupied a major portion of the revenue generated by the workflow segment as it accounts for the most complex and important step of Next-Generation Sequencing, which is directly linked with the interpretation of results
• In-house mode dominated the market in 2020 and is expected to maintain its dominance during the forecast period
• However, the outsourced mode is expected to register the fastest CAGR from 2021 to 2028 owing to the time and cost benefits associated with this mode and the presence of key players offering data analysis services
• The short-read sequencing segment led the global market in 2020 due to the wide adoption of these techniques as they are inexpensive and can work with fragment DNA along with the availability of several tools and algorithms
• The academic research end-use segment generated the largest revenue in 2020; however, clinical research is estimated to be the fastest-growing segment from 2021 to 2028
• North America dominated the global market in 2020 owing to the launch of large-scale genome sequencing projects and the rise in demand for personalized medicine

Next-Generation Sequencing Data Analysis Market Segmentation

Grand View Research has segmented the global next-generation sequencing data analysis market on the basis of product, workflow, mode, read length, end-use, and region:

Next-Generation Sequencing Data Analysis Product Outlook (Revenue, USD Million, 2017 - 2028)

• Services
• NGS Commercial Software
  • Platform OS/UI
  • Analytical Software
    • Alignment Tools & Software
      • DNA Seq Alignment
      • RNA Seq Alignment
      • Protein Seq Alignment
    • QC/Pre-processing Tools
    • Others

Next-Generation Sequencing Data AnalysisWorkflow Outlook (Revenue, USD Million, 2017 - 2028)

• Primary
• Secondary
  • Read Mapping
  • Variant Alignment & Variant Calling
• Tertiary
  • Variant Annotation
  • Application-specific
    • Targeted Sequencing/Gene Panel
    • Exome Sequencing
    • RNA Sequencing
    • Whole Genome Sequencing
    • ChIP-sequencing
    • Others

Next-Generation Sequencing Data AnalysisMode Outlook (Revenue, USD Million, 2017 - 2028)

• In-house
• Outsourced

Next-Generation Sequencing Data AnalysisRead Length Outlook (Revenue, USD Million, 2017 - 2028)

• Short Read
• Long Read
• Very Long Read

Next-Generation Sequencing Data AnalysisEnd-use Outlook (Revenue, USD Million, 2017 - 2028)

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Other Users

Next-Generation Sequencing Data Analysis Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of Next-Generation Sequencing (NGS) Data Analysis Market

• Thermo Fisher Scientific, Inc.
• QIAGEN
• Illumina, Inc.
• Hoffmann-La Roche Ltd.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• PierianDx
• Intrexon Bioinformatics Germany GmbH
• Partek, Inc.
• Eurofins Scientific
• Pacific Biosciences of California, Inc.
• DNASTAR, Inc.
• Congenica Ltd.
• Fabric Genomics, Inc.
• Genuity Science
• DNAnexus Inc.
• SciGenom Labs Pvt. Ltd.
• Golden Helix, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

mHealth Market Emerging Trends , Industry Growth At Regional Level And Forecast Till 2028: Grand View Research Inc.

 

mHealth Market Growth & Trends

The global mHealth market size is expected to reach USD 166.2 billion by 2028 and is expected to expand at a CAGR of 17.6% over the forecast period, according to a new report by Grand View Research, Inc. Growing penetration of smartphones & internet connectivity, rising adoption of mHealth platforms and technologies by patients and physicians, and supportive government initiatives are among the key factors driving the market growth. Rising demand for preventive healthcare and increasing funding for the mHealth startups are also projected to propel the market growth.

In addition, the Covid-19 pandemic has led to increased utilization of mHealth technologies due to increased adoption of remote patient monitoring and diagnosis & analysis of patient data. For instance, according to data published by Statista, the number of medical apps downloaded during the peak months of the pandemic as compared to the number of downloads in January 2020 demonstrated a considerable spike. In India, in particular, there was around a 90% increase in the medical apps' downloads during the peak months of the pandemic.

Based on participants, mobile operators accounted for the highest revenue share in the market owing to improvements in the network infrastructure, increase in the use of 4G & 3G technologies, and rise in the number of mobile subscribers. A rise in the number of industry partnerships is another significant factor driving the segment growth. For instance, in 2019, OneLife, a mobile medical software company, partnered with AT&T for the development of a health-tracking watch to monitor a patient’s heart rate, location, sleep, and movement.

North America dominated the global market with a revenue share of over 38% in 2020 owing to various factors including high healthcare expenditure, increased geriatric population, high prevalence of chronic diseases, and improved network infrastructure. Favorable government initiatives and increasing adoption of mobile health apps are anticipated to the regional market during the forecast period.

Request a free sample copy or view report summary: mHealth Market Report

mHealth Market Report Highlights

• mHealth apps segment dominated the market in 2020 owing to increased penetration of smartphones & the internet and high awareness levels about mobile health applications among healthcare professionals
• The segment will expand further at the fastest CAGR from 2021 to 2028 due to the growing adoption and visibility of such apps to create affirmative health outcomes along with the rising preference for mobile apps by healthcare professionals and patients
• The monitoring services segment dominated the market in 2020 owing to increased incidence of chronic diseases and demand for remote monitoring systems in post-acute care and independent aging solutions
• Increased number of market players investing in mHealth services for patient monitoring is also expected to propel the segment
• Monitoring services primarily involve the observation of diseases, health conditions, or other critical medical parameters for a defined time

mHealth Market Segmentation

Grand View Research has segmented the global mHealth market on the basis of component, services, participants, and region:

mHealth Component Outlook (Revenue, USD Million, 2016 - 2028)

• Wearables
  • BP Monitors
  • Glucose Meters
  • Pulse Oximeters
  • Sleep Apnea Monitors (PSG)
  • Neurological Monitors
  • Activity Trackers/Actigraphs
• mHealth Apps
  • Medical Apps
    • Women’s Health
    • Personal Health Record Apps
    • Medication Management Apps
    • Disease Management Apps
    • Diagnostic Apps
    • Remote Monitoring Apps
    • Others
  • Fitness Apps
    • Exercise & Fitness
    • Diet & Nutrition
    • Lifestyle & Stress

mHealth Services Outlook (Revenue, USD Million, 2016 - 2028)

• Monitoring Services
  • Independent Aging Solutions
  • Chronic Disease Management & Post-acute Care Services
• Diagnosis Services
• Healthcare Systems Strengthening Services
• Others

mHealth Participants Outlook (Revenue, USD Million, 2016 - 2028)

• Mobile Operators
• Device Vendors
• Content Players
• Healthcare Providers

mHealth Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of mHealth Market

• AT&T
• Telefonica S.A.
• SoftServe
• Google, Inc.
• Airstrip Technologies, Inc.
• Samsung Electronics Co. Ltd.
• Allscripts Healthcare Solutions
• Apple, Inc.
• Orange
• mQure
• Qualcomm Technologies, Inc.
• Vodafone Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Anti-money Laundering Market Factors Hindering The Growth Rate, Challenges and Restraints For Business Development

 Anti-money Laundering Market Growth & Trends

The global anti-money laundering market size is expected to reach USD 3.19 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 15.6% from 2021 to 2028. The growth can be attributed to the growing volume of non-cash transactions, coupled with a rise in technological developments in the fintech sector. In recent years, banks have increased their IT expenditure toward the adoption of advanced solutions and technologies to improve the security of their services and products.

The rapid developments in artificial intelligence, big data, machine learning, and other technologies are creating new opportunities for the market. The rising risk of financial crimes and fraudulent transactions, arising from factors such as the vulnerabilities inherent to digitization and automation, is compelling financial institutions to employ technologies such as machine learning for identifying suspicious transactions on a real-time basis. As a result, various companies are making efforts to deploy machine learning capabilities in anti money laundering solutions. For instance, in November 2020, Computer Services, Inc., a provider of end-to-end regtech and fintech solutions, announced a partnership with Featurespace, an enterprise financial crime prevention software provider. Through this partnership, the companies launched the WatchDOG AML, which uses machine learning capabilities to identify suspicious activities on a real-time basis.

Government bodies across the world are making efforts to promote awareness about anti money laundering regulations. For instance, in 2019, the New Zealand government spent USD 1.083 million on Keep Our Money Clean, an anti money laundering campaign. Through this campaign, the government tried to create public awareness regarding the legislative changes in anti money laundering acts to enable related businesses to educate their customers about new obligations.

The COVID-19 pandemic is anticipated to impact the market growth favorably in near future. The pandemic has led to an increase in the use of mobile-based payment solutions, remote work, and online sales, which are some of the major factors driving the demand for anti money laundering solutions globally. Financial Action Task Force an intergovernmental organization has encouraged financial institutions to provide risk-based flexibility in the implementation of anti money laundering in response to the effects of the pandemic.

Request a free sample copy or view report summary: Anti-money Laundering Market Report

Anti-money Laundering Market Report Highlights

• In terms of component, the software segment is expected to retain its dominance over the forecast period. This can be attributed to the fact that software can help organizations reduce the legal risk associated with money laundering activities
• In terms of product type, the customer identity management segment dominated the market in 2020 and is expected to witness promising growth during the forecast period as well. Advancements in technologies that can easily access an individuals' personal information have increased the demand for customer identity management solutions
• In terms of deployment, the on-premise segment dominated the market in 2020. The on-premise deployment of anti money laundering solutions grants businesses full control over the applications, platforms, systems, and data that their in-house IT teams can handle
• In terms of end use, the BFSI segment dominated the market in 2020. The BFSI sector is widely adopting anti money laundering solutions as they help financial institutions to efficiently comply with national and international regulations as well as provide secured services to customers
• Increasing money laundering cases in emerging economies, such as China and India, are expected to create growth opportunities for the market in the Asia Pacific region over the forecast period

Anti Money Laundering Market Segmentation

Grand View Research has segmented the global anti-money laundering market on the basis of component, product type, deployment, end-use, and region:

Anti-money Laundering Component Outlook (Revenue, USD Million, 2016 - 2028)

• Software
• Services

Anti-money Laundering Product Type Outlook (Revenue, USD Million, 2016 - 2028)

• Compliance Management
• Currency Transaction Reporting
• Customer Identity Management
• Transaction Monitoring

Anti-money Laundering Deployment Outlook (Revenue, USD Million, 2016 - 2028)

• Cloud
• On-premise

Anti-money Laundering End-use Outlook (Revenue, USD Million, 2016 - 2028)

• BFSI
• Government
• Healthcare
• IT & Telecom
• Others

Anti-money Laundering Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

List of Key Players of Anti-money Laundering Market

• NICE Actimize
• Tata Consultancy Services Limited
• Trulioo
• Cognizant Technology Solutions Corporation
• ACI Worldwide, Inc.
• SAS Institute Inc.
• Fiserv, Inc.
• Oracle Corporation
• BAE Systems
• Accenture

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nicotine Replacement Therapy Market Estimated to Experience a Hike in Growth by 2028

 Nicotine Replacement Therapy Market Growth & Trends

The global nicotine replacement therapy market size is expected to reach USD 147.9 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 16.3% from 2021 to 2028. The growth of the market is largely attributed to increasing government initiatives to promote nicotine replacement therapy (NRT) products for reducing mortality due to smoking and diseases associated with it.

Smoking cessation campaigns are also playing a crucial role in increasing awareness about diseases that are caused because of smoking. These campaigns are run by regional governments as well as multinational companies, such as Philip Morris International and Altria. Global organizations like the WHO are also working toward creating awareness by running online campaigns. 

There has been an exponential increase in the usage of NRT products. The young population is the largest consumer of advanced NRT products, like heat-not-burn tobacco and e-cigarettes. However, middle-aged patients’ interest in smoking cessation has led to a rise in the usage of e-cigarettes. For instance, the use of e-cigarettes for smoking cessation increased to 20% in 2018 from 13% in 2016 among people aged 45 to 54 years.

Furthermore, researchers found that 5% to 9% of smokers tend to use nicotine patches even after the therapeutic period of 12 weeks. The passive approach of combining nicotine patches with a gum, inhaler, or spray is found to be more effective, and quitting rate reaching 34% to 54%. NRT is only recognized as a way of curbing nicotine cravings and treatment by consumers.

With technological advancements, the players in this market are also developing products to suit the changing consumer preferences. For instance, the e-cigarette market is changing with newer innovations that are more efficient, have longer battery life, and are rechargeable. The existing innovations like sleek and easy-to-use socially acceptable e-cigarettes brought a revolution, which drove more people to shift to using NRTs without social stigma.

Various players such as Nicocigs Ltd.; Nicoventures Ltd.; Victory Electronic Cigarettes Corp.; DuraSmoke; AlternaCig; Shenzhen IVPS Technology CO. Limited; and Vapor Group, Inc. are launching e-cigarettes and related products. Although there are hundreds of companies selling e-cigarettes, their usage in NRT is disputed.

Request a free sample copy or view report summary: Nicotine Replacement Therapy Market Report

Nicotine Replacement Therapy Market Report Highlights

• By product, the e-cigarettes segment held the largest NRT market share in 2020 due to increasing investments and the rising focus of companies on developing value-added products. The heat-not-burn tobacco products segment is expected to grow at the fastest rate over the forecast period
• The offline distribution channel segment dominated the market in 2020. Retail chains across the world are investing in advanced technologies and undertaking new initiatives in order to improve sales and attract more customers. The increasing sales of e-cigarettes through vape shops and retail stores is another factor augmenting the growth of this segment
• Asia Pacific held the largest market share in 2020. Favorable government initiatives, coupled with an evolving reimbursement landscape for pharmaceutical products, are supporting continual growth

Nicotine Replacement Therapy Market Segmentation

Grand View Research has segmented the global nicotine replacement therapy market by product, distribution channel, and region:

NRT Product Outlook (Revenue, USD Billion, 2017 - 2028)

• Nicotine Replacement Therapy
  • Inhalers
  • Gum
  • Transdermal Patches
  • Sublingual Tablets
  • Lozenges
  • Others
• E-cigarettes
• Heat-not-burn Tobacco Products

NRT Distribution Channel Outlook (Revenue, USD Billion, 2017 - 2028)

• Offline
• Online

NRT Regional Outlook (Revenue, USD Billion, 2017 – 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Nicotine Replacement Therapy Market

• Philip Morris Products S.A. (Altria Group)
• British American Tobacco p.l.c.
• Japan Tobacco, Inc.
• Imperial Brands
• Glenmark
• Fertin Pharma
• Cipla Inc.
• Pfizer Inc.
• Johnson & Johnson Services, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Wires And Cables Market Competitive Insight and Key Drivers 2021 to 2028

 Wires And Cables Market Growth & Trends

The global wires and cables market size is expected to reach USD 260.16 billion by 2028, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 4.4% from 2021 to 2028. Wires and cables are one of the essential components of infrastructure development across the world. The growing emphasis on investments and government initiatives to generate power from renewable sources has enforced the adoption of wires and cables across the globe. Increasing funds in the upgradation of infrastructure and the demand for refined power transmission and distribution systems are the key factors driving the market over the forecast period.

Infrastructure development, modernization, and upgradation of infrastructure such as railways, tunnels, tunnel-lighting and signaling; commercial, residential, and industrial buildings; and implementation of smart grid technology is expected to drive the global market. Sectors such as defense, aerospace, and telecom are moving towards new infrastructure and construction, which increases the demand for cables and wires across the globe. Technological upgrades require various services, such as internet access and communication. Expansions and upgrades will directly increase the demand for cables such as communication cables, instrumentation cables, Ethernet cables, and others.

The government initiatives in rural electrification also play a vital role in the growth of the overall market. Rural electrification entails actions, including setting electricity infrastructure, improving communication, and providing connectivity to households. Rural electrification is anticipated to drive the demand for wires and cables in the coming years. For instance, according to the Ministry of Power - Government of India, 26.3 million homes below the poverty line have been electrified under the Rural Electrification section of Deen Dayal Upadhyay Gram Jyoti Yojana (DDUGJY). Smart grids diminish the general cost incurred in traditional systems, including the operational cost encountered due to loss of power. It also lowers the pressure on energy prices and total customer bills. The Indian government, under the "Make in India" campaign, has targeted the installation of 130 million smart meters by 2021 under Smart City Initiatives. The installation was done at the consumer base, where the monthly consumption is above 200 units by 2019. There are various steps taken by the government in other countries, such as the U.S., to encourage the smart grid implementation.

Request a free sample copy or view report summary: Wires And Cables Market Report

Wires And Cables Market Report Highlights

• The global market accounted for USD 183.14 billion in 2020 and is expected to grow at a CAGR of 4.4% from 2021 to 2028. 
• The extra-high voltage segment emerged as the fastest-growing segment over the forecast period. 
• Overhead emerged as the largest segment in 2020 and is estimated to generate revenue of over USD 165.17 billion by 2028. 
• The Asia Pacific market held the largest share in the market in 2020. Government initiatives such as Make in India and Smart Cities in the region are anticipated to drive the market.
• Key players including Prysmian SpA, Nexans, Belden Inc., LS Cables & System Ltd., Furukawa Electric Co., Ltd., Fujikura Ltd., Sumitomo Corporation, Leoni AG, NKT A/S, among others accounted for the majority share of the overall market in 2020.

Wires and Cables Market Segmentation

Grand View Research has segmented the global wires and cables market on the basis of voltage, installation, end-use, and region:

Wires And Cables Voltage Outlook (Revenue, USD Billion, 2017 - 2028)

• Low Voltage
• Medium Voltage
• High Voltage
• Extra High Voltage

Wires And Cables Installation Outlook (Revenue, USD Billion, 2017 - 2028)

• Overhead
• Underground

Wires And Cables End-use Outlook (Revenue, USD Billion, 2017 - 2028)

• Aerospace & Defense
• Building & Construction
• Oil & Gas
• Energy & Power
• IT & Telecommunication
• Others

Wires And Cables Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• South America
  • Brazil
• Middle East & Africa

List of Key Players of Wires And Cables Market

• Belden Inc.
• Fujikura Ltd.
• Furukawa Electric Co., Ltd.
• Leoni AG
• LS Cables & System Ltd.
• Nexans
• NKT A/S
• Prysmian SpA
• Sumitomo Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Augmented Reality Market Top Players, Analysis And Forecast Till 2028: Grand View Research Inc.

 Augmented Reality Market Growth & Trends

The global augmented reality market size is estimated to reach USD 340.16 billion by 2028, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 43.8% from 2021 to 2028. Continued innovations in the Augmented Reality (AR) realm, which have triggered the adoption of the technology in several industries and industry verticals, is fueling market growth. People are increasingly adopting the AR-supported online platforms for shopping, education, and social media interactions, among other purposes, for a better immersion experience. The introduction of Website-based AR (WebAR), a digital technology that allows users to directly access AR on the internet without having to download any application, is expected to create substantial opportunities for the market growth.

E-commerce sales are on the rise as brick and mortar retail stores remain temporarily shut, in various parts of the world in the wake of the COVID-19 pandemic. Hence, several businesses are launching new products online and adopting AR technology to provide an immersive experience to buyers. AR and 3D visualization are allowing consumers to experience products virtually in real time before making a buying decision.

The adoption of AR technology in the education industry is also gaining traction owing to the potential of the technology to help students in experiencing a more detailed and live explanation of informative concepts. The adoption of augmented reality in the education industry is poised for significant growth over the forecast period as several educational institutions are shifting their courses and lectures to virtual event platforms in the wake of the COVID-19 pandemic.

Request a free sample copy or view report summary: Augmented Reality Market Report

Augmented Reality Market Report Highlights

• Smartphone proliferation and widescale adoption of AR in mobile games are expected to drive the growth of the market
• The handheld devices display segment is anticipated to exhibit the highest CAGR of over 45.0% from 2021 to 2028
• The industrial and manufacturing application segment accounted for the highest revenue share in 2020
• The Asia Pacific regional market is expected to register the highest CAGR over the forecast period

Augmented Reality Market Segmentation

Grand View Research has segmented the global augmented reality market based on component, display, application, and region:

AR Component Outlook (Revenue, USD Million, 2016 - 2028)

• Hardware
• Software

AR Display Outlook (Revenue, USD Million, 2016 - 2028)

• HMD & Smart Glass
• HUD
• Handheld Devices

AR Application Outlook (Revenue, USD Million, 2016 - 2028)

• Aerospace & Defense
• Automotive
• Education
• E-commerce & Retail
• Gaming & Entertainment
• Healthcare
• Industrial & Manufacturing
• Others

AR Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Latin America
  • Brazil
• Middle East & Africa

List of Key Players in the Augmented Reality Market

• Google, LLC
• Sony Corporation
• Facebook LLC
• Magic Leap, Inc.
• Samsung Electronics Co., Ltd.
• HTC Corporation
• Wikitude GmbH

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Gypsum Board Market Expected To Hit CAGR of 11.8% By 2028

 

Gypsum Board Market Growth & Trends

The global gypsum board market size is expected to reach USD 109.95 billion by 2028 registering a CAGR of 11.8%, according to a new report by Grand View Research Inc. Increasing utilization of gypsum boards in decorative and partitioning applications in residential constructions is anticipated to drive the market over the forecast period. Rise in the construction industry across the globe is likely to provide growth opportunities to the market. The product demand is also driven by the residential sector, wherein, it is widely used for room partitioning.

These products are available in the form of wallboards, ceiling boards, pre-decorated boards, etc., which also boosts their demand in the construction application. Moreover, high durability and low weight of the product coupled with easy handling measures have propelled its demand in commercial, institutional, and industrial facilities for impact & mold resistance, exterior sheathing, and shaft wall constructions. Moreover, the availability of decorative designs on the boards is likely to support the growth over the forecast period. The U.S. Environmental Protection Agency (EPA) has approved the use of Flue Gas Desulphurization (FGD) Gypsum as a substitute to mined gypsum for the production of wallboards.

Request a free sample copy or view report summary: Gypsum Board Market Report

Gypsum Board Market Report Highlights

• The wallboard segment led the global market in 2020 and will expand at a steady CAGR over the projected period owing to the wide utilization of wallboards in partitioning and decorative applications, majorly in multi-family residential constructions
• In 2020, the residential application segment dominated the global market with a share of over 47% and is projected to ascend at the fastest CAGR over the forecast period
• The residential application segment growth can be attributed to the rising need for the construction of multi-family houses in regions, such as Asia Pacific and North America
• North America accounted for the largest market share of over 42% in 2020 on account of the well-established construction industry and quick adoption of advanced construction materials
• Saint-Gobain was the leading market player with gypsum solutions offered under brands, such as CertainTeed, British Gypsum, Gyproc, Rigips, and Placo

Gypsum Board Market Segmentation

Grand View Research has segmented the global gypsum board market on the basis of product, application, and region:

Gypsum Board Product Outlook (Volume, Million Square Meters; Revenue, USD Million, 2017 - 2028)

• Wallboard
• Ceiling Board
• Pre-decorated Board
• Others

Gypsum Board Application Outlook (Volume, Million Square Meters; Revenue, USD Million, 2017 - 2028)

• Pre-engineered Buildings
• Residential
• Industrial
• Commercial
• Institutional

Gypsum Board Regional Outlook (Volume, Million Square Meters; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Central & South America
  • Brazil
• Middle East & Africa
  • Bahrain
  • Kuwait
  • Qatar
  • Oman
  • Saudi Arabia
  • UAE
  • Jordan
  • Iraq
  • Iran
  • Egypt
  • Syria
  • Turkey
  • Libya
  • Sudan

List of Key Players of Gypsum Board Market

• Saint-Gobain Gyproc
• Knauf Gips KG
• Gulf Gypsum Co.
• USG Corp.
• National Gypsum Company
• LafargeHolcim Ltd.
• Georgia-Pacific LLC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Next Generation Sequencing Market Poised to Expand at a Robust Pace of $11.7 Billion Over 2028

 

Next Generation Sequencing Market Growth & Trends

The global next generation sequencing market size is anticipated to reach USD 11.7 billion by 2028 registering a CAGR of 14.4%, according to a new report by Grand View Research, Inc. As researchers are continuously unlocking the genetic diversity, the development of targeted therapies is on the rise. These therapies are targeted towards narrow populations of patients that have specific or rare genomic biomarkers. Therefore, this is expected to increase the utilization of next generation sequencing (NGS) technology for targeted therapies.

Simplification in the NGS workflow coupled with the continued price reductions in instruments as well as reagents is attributed to the increasing adoption of this technology. The cost of sequencing the human genome has reduced from USD 100 million to less than USD 1,000 in less than two decades. Moreover, enhancement in the bioinformatics capabilities will lead to broadening of NGS adoption at the low- and high-throughput ends of the research market.

Several companies are engaged in the innovation of long-read sequencing technologies, which will augment the research as well as clinical application sets. The growing automation in the pre- & post-sequencing protocols, and data analysis is also driving the market. The utilization of novel platforms for the development of personalized medicine at a genetic level is also a significant factor, which is expected to boost the demand for NGS over the forecast period.

Request a free sample copy or view report summary: Next Generation Sequencing Market Report

Next Generation Sequencing Market Report Highlights

• The oncology application segment accounted for the largest revenue share in 2020 and will retain its dominance throughout the forecast period due to the development and launch of targeted gene panels for oncology
• Companies like Myriad Genetics, Inc., through its myRisk product, offer genetic testing to identify people who may be at a higher risk of developing certain cancers in the future
• The high utility of NGS technology in the identification of coronavirus strains is expected to drive the infectious diseases segment with the fastest CAGR from 2021 to 2028
• Sequencing was the largest revenue-generating workflow segment in 2020 due to the introduction of novel, portable sequencers as a result of high competition
• In addition, owing to the expected increase in adoption and usage of WGS, sequencing is expected to witness the fastest CAGR over the forecast period
• The clinical research end-use segment is expected to register the fastest CAGR from 2021 to 2028. An increase in the utility of NGS technology and the support of key players for Covid-19 research is responsible for the segment growth
• For instance, in January 2021, to support the Covid-19 surveillance and research, Thermo Fisher Scientific extended its SARS-CoV-2 GlobalAccess Sequencing Program to offer additional units of Ion GeneStudio S5 sequencer and Ion Torrent Genexus System at a subsidized rate
• North America was the largest regional market owing to significant developments in the fields of companion diagnostics, personalized medicine, and NGS
• Asia Pacific is projected to be the fastest-growing regional market from 2021 to 2028 owing to the expansion of the molecular diagnostics field and high investments by global and local players in the Asian countries
• For instance, in January 2021, Crown Bioscience, Inc.; a U.S.-based platform technology innovator; launched NGS panel services at its Center of Translational Science in Suzhou, China

Next Generation Sequencing Market Segmentation

Grand View Research has segmented the global next generation sequencing market on the basis of technology, application, workflow, end-use, and region:

NGS Technology Outlook (Revenue, USD Million, 2017 - 2028)

• WGS
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing
  • DNA-based
  • RNA-based

NGS Application Outlook (Revenue, USD Million, 2017 - 2028)

• Oncology
  • Diagnostics and Screening
    • Oncology Screening
      • Sporadic Cancer
      • Inherited Cancer
    • Companion Diagnostics
    • Other Diagnostics
  • Research Studies
• Clinical Investigation
  • Infectious Diseases
  • Inherited Diseases
  • Idiopathic Diseases
  • Non-Communicable/Other Diseases
• Reproductive Health
  • NIPT
    • Aneuploidy
    • Microdeletions
  • PGT
  • Newborn Genetic Screening
  • Single Gene Analysis
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Agrigenomics & Forensics
• Consumer Genomics

 NGS Workflow Outlook (Revenue, USD Million, 2017 - 2028)

• Pre-Sequencing
  • NGS Library Preparation Kits
  • Semi-automated Library Preparation
  • Automated Library Preparation
  • Clonal Amplification
• Sequencing
• NGS Data Analysis
  • NGS Primary Data Analysis
  • NGS Secondary Data Analysis
  • NGS Tertiary Data Analysis

NGS End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Other Users

NGS Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Italy
  • Spain
  • France
• Asia Pacific
  • Japan
  • China
  • South Korea
  • Australia
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Next Generation Sequencing Market

• Illumina
• QIAGEN
• Thermo Fisher Scientific, Inc.
• Hoffman-La Roche Ltd.
• Oxford Nanopore Technologies
• Genomatix GmbH
• PierianDx
• DNASTAR, Inc.
• Eurofins GATC Biotech GmbH
• Perkin Elmer, Inc.
• BGI
• Bio-Rad Laboratories, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Clinical Laboratory Service Market Soaring Demand Assures Motivated Revenue Share By 2028

 Clinical Laboratory Service Market Growth & Trends

The global clinical laboratory service market size is expected to reach USD 288.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.7% from 2021 to 2028. Growing prevalence of target diseases such as diabetes and cardiovascular diseases is expected to positively impact the market growth over the forecast period. For instance, according to the WHO, by 2030, cardiovascular diseases are estimated to cause approximately 23.6 million deaths, mainly from heart disease and stroke.

The COVID-19 pandemic, caused due to SARS-CoV-2, is affecting millions of people globally. According to WHO and CDC, the standard for laboratory diagnosis of COVID-19 is Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for samples collected from the respiratory tract. The adoption of PCR technology for the diagnosis of COVID-19 and the genetic sequencing of the virus for the development of a cure are driving the market.

Furthermore, in May 2020, the Department of Health and Human Services (HHS) provided more than USD 200 million to clinics in rural areas of the U.S. to expedite COVID-19 testing. Such robust investments by government bodies to increase adoption of COVID-19 diagnostic kits by clinics are anticipated to boost segment growth. COVID-19 walk-up clinics in San Jose are another key initiative expected to positively impact segment growth.

In addition, advancements in laboratory testing technology through incremental and breakthrough developments are expected to serve this market as a high impact rendering driver. For instance, in March 2020, a Singapore-based med-tech company, Biolidics, launched a rapid test kit for COVID-19 and entered into a manufacturing agreement with a diagnostic kit manufacturer for mass production.

Automation in clinical settings has significantly improved the data management process in labs. Improving adoption rates of laboratory automation systems is expected to boost the market throughout the forecast period. Furthermore, database management tools, patient test records, and integrated workflow management systems have received significant consideration in the healthcare industry.

Request a free sample copy or view report summary: Clinical Laboratory Service Market Report

Clinical Laboratory Service Market Report Highlights

• In 2020, the clinical chemistry segment held majority of revenue share owing to presence of large number of tests due to increasing knowledge on clinical chemistry
• Stand-alone laboratories is expected to witness lucrative growth rate over the forecast period due to introduction of digital support systems to manage large databases and ability to provide better clinical laboratory services at a comparatively lower rate
• The bioanalytical and lab chemistry services segment dominated the market in 2020 owing to rising use of wide range of techniques and technology platforms to fulfill diagnostic needs
• In Asia Pacific, the market is projected to witness the fastest growth over the forecast period owing to a growing awareness, increased government initiatives, and positive regulatory policies
• North America dominated the market in 2020 due to technological advancements and high awareness on medical standards

Clinical Laboratory Service Market Segmentation

Grand View Research has segmented the global clinical laboratory service market on the basis of test type, service provider, application, and region:

Clinical Laboratory Services Test Type Outlook (Revenue, USD Billion, 2017 - 2028)

• Human & Tumor Genetics
• Clinical Chemistry
• Medical Microbiology & Cytology
• Other Esoteric Tests

Clinical Laboratory Services Provider Outlook (Revenue, USD Billion, 2017 - 2028)

• Hospital-Based Laboratories
• Stand-Alone Laboratories
• Clinic-Based Laboratories

Clinical Laboratory Services Application Outlook (Revenue, USD Billion, 2017 - 2028)

• Bioanalytical & Lab Chemistry
• Toxicology Testing
• Cell & Gene Therapy Related Services
• Preclinical & Clinical Trial Related Services
• Drug Discovery & Development Related Services
• Others

Clinical Laboratory Services Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Colombia
  • Peru
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Clinical Laboratory Service Market

• Qiagen
• OPKO Health, Inc.
• Charles River Laboratories
• International, Inc
• Sonic Healthcare
• Almac Group
• Laboratory Corporation of America Holdings (LabCorp)
• DaVita, Inc.
• Viapath Group LLP
• Abbott
• SGS SA
• Quest Diagnostics, Inc.
• NeoGenomics Laboratories, Inc.
• Siemens Healthcare GmbH
• Fresenius Medical Care
• Cinven
• Arup Laboratories

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Anti-acne Cosmetics Market Booming Trends and Forecast Assessment for the Period 2021 to 2028

 Anti-acne Cosmetics Market Growth & Trends

The global anti-acne cosmetics market size is expected to reach USD 4.7 billion by 2028 registering a CAGR of 9.1%, according to a new report by Grand View Research, Inc. The high psychological burden associated with acne, especially among women, is expected to be the key growth-driving factor for the market. Moreover, the easy availability of various products to treat acne is anticipated to support the market growth. According to the American Academy of Dermatology, it is one of the common skin disorders in the U.S., affecting approximately 50 million individuals every year, with nearly 85% of individuals between the age group of 12 and 24 years having minor acne. Thus, a high prevalence of this skin disorder is also anticipated to fuel the product demand, thereby augmenting the market growth.

Furthermore, according to a study conducted by SkinStore, an average American woman uses nearly 16 skincare products per day and spends approximately USD 8 each day on facial cosmetics products. Such beauty regimes are also anticipated to propel market growth. According to the University of Limerick study, the negative social stigma associated with this skin disorder reduces the quality of life of individuals, increases their psychological distress, and causes physical problems, such as headaches, sleep disturbance, and gastrointestinal issues. This is also anticipated to increase the product demand over the coming years.

Request a free sample copy or view report summary: Anti-acne Cosmetics Market Report

Anti-acne Cosmetics Market Report Highlights

• The creams & lotions segment dominated the market in 2020 as the cream is the first line of therapy for all types of acne and it also provides skin moisturization
• The others product segment is expected to register the fastest CAGR over the forecast period due to the lightness of these products on the skin and compatibility with various skin types as compared to creams & lotions
• The women end-use segment held dominated share of the market in 2020 and is expected to grow at the fastest CAGR during the forecast period owing to a high prevalence of acne and other skin disorders
• Asia Pacific is anticipated to be the largest as well as the fastest-growing regional market from 2021 to 2028 due to increasing disposable income levels and growing population in developing countries

Anti-acne Cosmetics Market Segmentation

Grand View Research has segmented the global anti-acne cosmetics market on the basis of product type, end-use, and region:

Anti-acne Cosmetics Product Type Outlook (Revenue, USD Million, 2016 - 2028)

• Mask
• Creams & Lotions
• Cleansers & Toners
• Others

Anti-acne Cosmetics End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Women
• Men

Anti-acne Cosmetics Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Anti-acne Cosmetics Market

• Neutrogena
• Clinique
• Murad
• Kose
• LaRochPosay
• Mentholatum
• L'Oréal
• Proactiv
• Vichy

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Central Nervous System Therapeutic Market is Thriving USD 205.0 Billion Revenue by 2028

 Central Nervous System Therapeutic Market Growth & Trends

The global central nervous system therapeutic market size is expected to reach USD 205.0 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.4% from 2021 to 2028. High unmet medical needs and government initiatives to reduce the disease burden are driving the market for central nervous system (CNS) therapeutic over the forecast period. According to WHO, the global economy loses due to depression and anxiety is more than USD 1 trillion per year and rising patient base of mental health globally is expected to increase the economy loses by USD 16 trillion in 2030.

The market holds strong future growth opportunities and major players are adopting different marketing strategies such as new product development, collaborations, geographic expansion, mergers and acquisitions, and new product approval, to strengthen their positions. In February 2020, Biogen announced the investment in Sangamo’s zinc finger platform to develop therapies for Alzheimer’s disease and other neurological diseases. Similarly, the company has an agreement with Ionis Pharmaceutical for the development of drug candidates applicable across a wide range of neurological diseases.

Presence of strong pipeline products by major pharmaceutical companies such as Biogen, H. Lundbeck A/S, Eli Lilly and Company, and others are expected to accelerate market growth over the forecast period. Besides, other pharmaceutical companies are also actively involved in the development of novel therapies and investing heavily to develop effective therapeutics for the treatment of CNS associated diseases.

Most of the late phase development drugs are for the treatment of neurodegenerative disorders such as Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, and amyotrophic lateral sclerosis. The drug candidates such as aducanumab, brexpiprozole, evobrutinib, solanezumab are some of the potential drugs that could be commercialized in the next five to eight years for the treatment of various indication of neurodegenerative disorders. Apart from neurodegenerative diseases, migraine, schizophrenia, and epilepsy are the major CNS disease indications that have potential drug candidates in pipeline.

The cancer segment is expected to witness the fastest growth rate over the forecast period. Increasing prevalence, high mortality rate, and rising demand for effective treatment are expected to fuel the growth of the market for CNS therapeutic. According to National Cancer Institute estimates, the number of new cases of CNS cancers was 23,890 whereas the number of deaths was 18,020 in the U.S. in 2020.

Pharmaceutical companies are adopting strategies such as product development, merger and acquisition, and collaboration to strengthen their position in market. For instance, Biogen has signed agreements with Ionis Pharmaceuticals, Atalanta Therapeutics, and Sangamo Therapeutics to develop novel therapeutics for the treatment of different disease indications of the central nervous system. Similarly, in January 2020, the CNS Pharmaceuticals has entered into a licensing agreement with MD Anderson Cancer Center to investigate WP1244, a designed DNA-binding agent to cross the blood-brain barriers for the potential treatment of brain cancers.

Request a free sample copy or view report summary: Central Nervous System Therapeutic Market Report

Central Nervous System Therapeutic Market Report Highlights

• The neurodegenerative diseases segment accounted for the largest revenue share of nearly 40.0% in 2020 and is anticipated to maintain its dominance over the forecast period
• Pipeline candidates such as aducanumab, brexpiprozole, evobrutinib, solanezumab are anticipated to drive the neurodegenerative disorder segment from 2021 to 2028
• The CNS cancer segment is expected to witness the fastest growth rate over the forecast period. Increasing demand for effective treatment is expected to drive the segment
• In Asia Pacific, the market is estimated to witness the fastest growth over the coming years owing to the increase in treatment rate and betterment of healthcare infrastructure in the region
• North America held a majority of share in 2020 due to high awareness level in the region and better reimbursement scenario

Central Nervous System Therapeutic Market Segmentation

Grand View Research has segmented the global central nervous system therapeutic market on the basis of disease and region:

CNS Therapeutic Disease Outlook (Revenue, USD Million, 2017 - 2028)

• Neurovascular Diseases
• CNS Trauma
• Mental Health
  • Anxiety Disorders
  • Epilepsy
  • Mood Disorders
  • Psychotic Disorders
  • Others
• Neurodegenerative Diseases
  • Alzheimer's Disease
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Huntington's Disease
  • Amyotrophic Lateral Sclerosis
  • Others
• Infectious Diseases
• CNS Cancer
• Others

CNS Therapeutic Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • India
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players of Central Nervous System Therapeutic Market

• Biogen
• Otsuka Pharmaceutical Co., Ltd.
• Eli Lilly and Company
• Merck & Co.
• Astra Zeneca
• Shire PLC
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Johnson & Johnson Services, Inc.
• Pfizer, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Rapid Medical Diagnostic Kits Market To Hold a High Potential for Growth by 2028

 Rapid Medical Diagnostic Kits Market Growth & Trends

The global rapid medical diagnostic kits market size is expected to reach USD 18.0 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.4% from 2021 to 2028. Rapid medical diagnostic kits enhance the speed of etiologic diagnosis of patients affected with chronic ailments. Moreover, speedy diagnosis is of paramount importance in individuals affected with infectious diseases. Thus, an increase in the number of manufacturers keen on exploring this space is driving the revenue in the market.

Key players are focusing on introducing novel medical supplies that require limited operational training, offer convenient usage, and ensure effective analysis. This is expected to propel the demand for rapid medical care among the industry’s target audience, which is inclusive of a general population affected with chronic diseases, coupled with the healthcare professionals determined to recommend an appropriate rapid medical evaluation.

The gradual shift toward point of care (POC) testing is also an important factor boosting the adoption of these test kits. Moreover, the recent pandemic outbreak of COVID-19 has piqued the interest of healthcare professionals in this industry space. High demand for portable testing kits in COVID-19 diagnostics is expected to make a significantly positive impact on the market expansion during the forecast period.

Novel rapid diagnostic tests are being developed that are expected to facilitate the prevention of infections along with antimicrobial stewardship. Newly developed tests are combined with Antimicrobial Stewardship (ASP) to optimize antimicrobial utilization as well as patient outcomes. Moreover, test kits with a broad scope of diagnosis and swift turnaround time are entering the space, offering lucrative opportunities for revenue growth.

For instance, in January 2021, Trinity Biotech’s Captia SARS-CoV-2 IgG ELISA rapid test secured the CE mark. The company has also stated that it has significant capacity for ELISA associated product manufacturewithin their current operations, aiding in speedy commercialization of this test kit across the globe.

Request a free sample copy or view report summary: Rapid Medical Diagnostic Kits Market Report

Rapid Medical Diagnostic Kits Market Report Highlights

• By product, over the counter (OTC) kits dominated the market in 2020 with a share of 54.3%. This is attributed to the routine adoption of OTC rapid diagnostic tests to ensure timely administration of an apt therapeutic intervention
• On the basis of technology, the lateral flow segment held the largest share of 35.1% in 2020. Convenient manufacturing protocols, coupled with low costs associated with the development, have led to the expansion of lateral flow assays into the rapid medical diagnostic market space
• The blood glucose testing application segment is estimated to expand at the fastest CAGR of 4.1% from 2021 to 2028. The imperative need for routine blood glucose monitoring in diabetic patients has contributed to the segment’s revenue generation capacity
• Based on end use, hospitals and clinics accounted for the largest revenue share in 2020 owing to the maximum adoption of rapid medical diagnostic kits
• Market entities are actively participating in the development of rapid medical test products to address the current pandemic outbreak of COVID-19, further intensifying the market competition

Rapid Medical Diagnostic Kits Market Segmentation

Grand View Research has segmented the global rapid medical diagnostic kits market on the basis of product, technology, application, end use, and region:

Rapid Medical Diagnostic Kits Product Outlook (Revenue, USD Million, 2017 - 2028)

• Over the Counter (OTC) Kits
• Professional Kits

Rapid Medical Diagnostic Kits Technology Outlook (Revenue, USD Million, 2017 - 2028)

• Lateral Flow
• Agglutination
• Solid Phase
• Other Technologies

Rapid Medical Diagnostic Kits Application Outlook (Revenue, USD Million, 2017 - 2028)

• Blood Glucose Testing
• Infectious Disease Testing
• Cardiometabolic Testing
• Pregnancy and Fertility Testing
• Fecal Occult Blood Testing
• Coagulation Testing
• Toxicology Testing
• Lipid Profile Testing
• Other Applications

Rapid Medical Diagnostic Kits End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Hospitals & Clinics
• Home Care
• Diagnostic Laboratories

Rapid Medical Diagnostic Kits Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Rapid Medical Diagnostic Kits Market

• ACON Laboratories, Inc.
• Abbott Laboratories
• Artron Laboratories Inc.
• Alfa Scientific Designs, Inc.
• Becton, Dickinson and Company
• BTNX, Inc.
• bioMérieux SA
• Cardinal Health
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Creative Diagnostics
• Meridian Bioscience, Inc.
• Hoffmann-La Roche AG
• McKesson Medical-Surgical, Inc
• Sight Diagnostics Ltd
• Trinity Biotech
• Zoetis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nicotine Replacement Therapy Market Precise Analysis on Business Overview, Product Scope And Ongoing Development

 Nicotine Replacement Therapy Market Growth & Trends

The global nicotine replacement therapy market size is expected to reach USD 147.9 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 16.3% from 2021 to 2028. The growth of the market is largely attributed to increasing government initiatives to promote nicotine replacement therapy (NRT) products for reducing mortality due to smoking and diseases associated with it.

Smoking cessation campaigns are also playing a crucial role in increasing awareness about diseases that are caused because of smoking. These campaigns are run by regional governments as well as multinational companies, such as Philip Morris International and Altria. Global organizations like the WHO are also working toward creating awareness by running online campaigns. 

There has been an exponential increase in the usage of NRT products. The young population is the largest consumer of advanced NRT products, like heat-not-burn tobacco and e-cigarettes. However, middle-aged patients’ interest in smoking cessation has led to a rise in the usage of e-cigarettes. For instance, the use of e-cigarettes for smoking cessation increased to 20% in 2018 from 13% in 2016 among people aged 45 to 54 years.

Furthermore, researchers found that 5% to 9% of smokers tend to use nicotine patches even after the therapeutic period of 12 weeks. The passive approach of combining nicotine patches with a gum, inhaler, or spray is found to be more effective, and quitting rate reaching 34% to 54%. NRT is only recognized as a way of curbing nicotine cravings and treatment by consumers.

With technological advancements, the players in this market are also developing products to suit the changing consumer preferences. For instance, the e-cigarette market is changing with newer innovations that are more efficient, have longer battery life, and are rechargeable. The existing innovations like sleek and easy-to-use socially acceptable e-cigarettes brought a revolution, which drove more people to shift to using NRTs without social stigma.

Various players such as Nicocigs Ltd.; Nicoventures Ltd.; Victory Electronic Cigarettes Corp.; DuraSmoke; AlternaCig; Shenzhen IVPS Technology CO. Limited; and Vapor Group, Inc. are launching e-cigarettes and related products. Although there are hundreds of companies selling e-cigarettes, their usage in NRT is disputed.

Request a free sample copy or view report summary: Nicotine Replacement Therapy Market Report

Nicotine Replacement Therapy Market Report Highlights

• By product, the e-cigarettes segment held the largest NRT market share in 2020 due to increasing investments and the rising focus of companies on developing value-added products. The heat-not-burn tobacco products segment is expected to grow at the fastest rate over the forecast period
• The offline distribution channel segment dominated the market in 2020. Retail chains across the world are investing in advanced technologies and undertaking new initiatives in order to improve sales and attract more customers. The increasing sales of e-cigarettes through vape shops and retail stores is another factor augmenting the growth of this segment
• Asia Pacific held the largest market share in 2020. Favorable government initiatives, coupled with an evolving reimbursement landscape for pharmaceutical products, are supporting continual growth

Nicotine Replacement Therapy Market Segmentation

Grand View Research has segmented the global nicotine replacement therapy market by product, distribution channel, and region:

NRT Product Outlook (Revenue, USD Billion, 2017 - 2028)

• Nicotine Replacement Therapy
  • Inhalers
  • Gum
  • Transdermal Patches
  • Sublingual Tablets
  • Lozenges
  • Others
• E-cigarettes
• Heat-not-burn Tobacco Products

NRT Distribution Channel Outlook (Revenue, USD Billion, 2017 - 2028)

• Offline
• Online

NRT Regional Outlook (Revenue, USD Billion, 2017 – 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Nicotine Replacement Therapy Market

• Philip Morris Products S.A. (Altria Group)
• British American Tobacco p.l.c.
• Japan Tobacco, Inc.
• Imperial Brands
• Glenmark
• Fertin Pharma
• Cipla Inc.
• Pfizer Inc.
• Johnson & Johnson Services, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.